Ecolab Inc.
Rank #297ValueECL · NYSE · Basic Materials
Ecolab Inc. (ECL) — Rank #297 by gross profitability (GP/assets 0.24) · ROE 20.6% · Piotroski F-Score N/A.
As-of 2026-09-15 · CIK 0000031462 · all metrics point-in-time as of the filing date.
About
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally.
Show moreShow less
The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc.
was founded in 1923 and is headquartered in Saint Paul, Minnesota.
- Industry
- Specialty Chemicals
- Sector
- Basic Materials
- State
- DE
- Filer Category
- Large accelerated filer
- Fiscal Year End
- December 31
- Website
- ecolab.com
Financials
Stable
Direction over 5 fiscal years
- Free cash flowimproving
- Gross marginstable
- Gross profitabilityimproving
- Net cashimproving
- Operating marginimproving
- Return on equityimproving
- Share count (dilution)deteriorating
Red flags: fcf_ni_divergence_unfavorable — rating capped at Stable
Monitoring diagnostic of business direction — not a prediction of returns.
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2025-12-31filed 2026-02-23 | 2024-12-31filed 2025-02-21 | 2023-12-31filed 2024-02-23 | 2022-12-31filed 2023-02-24 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 16,081.2 | 15,741.4 | 15,320.2 | 14,187.8 |
| Revenue growth (YoY) | 2.2% | 2.7% | 8.0% | 11.4% |
| Gross profit | 7,150.4 | 6,841.7 | 6,165.3 | 5,356.8 |
| Gross margin | 44.5% | 43.5% | 40.2% | 37.8% |
| Net income | 2,075.6 | 2,112.4 | 1,372.3 | 1,091.7 |
| Net margin | 12.9% | 13.4% | 9.0% | 7.7% |
| EPS (diluted) | $7.28 | $7.37 | $4.79 | $3.81 |
| EPS growth (YoY) | -1.2% | 53.9% | 25.7% | — |
| Cash flow | ||||
| Operating cash flow | 2,952.6 | 2,813.9 | 2,411.8 | 1,788.4 |
| Capital expenditures | 1,048.3 | 994.5 | 774.8 | 712.8 |
| Free cash flow | 1,904.3 | 1,819.4 | 1,637.0 | 1,075.6 |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?